Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2009

01-06-2009 | Epidemiology

Vitamin D receptor variants and breast cancer risk in the Polish population

Authors: P. Gapska, R. J. Scott, P. Serrano-Fernandez, T. Huzarski, T. Byrski, J. Kładny, J. Gronwald, B. Górski, C. Cybulski, J. Lubinski, T. Dębniak

Published in: Breast Cancer Research and Treatment | Issue 3/2009

Login to get access

Abstract

The aim of the study was to determine whether four VDR gene single nucleotide polymorphisms (SNPs: rs1544410, rs731236, rs10735810 and rs4516035) are associated with breast cancer risk in Polish population. Two independent series of female patients were employed: 960 consecutive breast cancer cases, and 800 unselected early onset cases diagnosed under the age of 51. The control group for the consecutive breast cancer cases consisted of 960 healthy, age-matched women with a negative cancer family history. 550 healthy women, aged 51 or less, with negative cancer family history were selected as the independent controls for the early onset breast cancer cases. The frequencies of the VDR polymorphisms in the unselected cases when compared to the respective control population failed to reveal any association between the individual SNPs and disease. Examination of the group of early-onset patients, revealed an association between rs10735810 and increased breast cancer risk. Heterozygous carriers for the change had an OR = 1.73 (95% CI 1.33–2.26, P < 0.0001) and homozygous carriers OR = 2.34 (95% CI 1.71–3.21, P < 0.0001). The remaining three examined SNPs failed to show any association with disease risk. In summary, this study has identified an association between the VDR gene and early onset breast cancer risk in the Polish population.
Literature
2.
go back to reference Trabert B, Malone KE, Daling JR et al (2007) Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case–control study of Caucasian and African–American women. Breast Cancer Res 9(6):R84. doi:10.1186/bcr1833 PubMedCrossRef Trabert B, Malone KE, Daling JR et al (2007) Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case–control study of Caucasian and African–American women. Breast Cancer Res 9(6):R84. doi:10.​1186/​bcr1833 PubMedCrossRef
5.
go back to reference Gross C, Ecceleshall TR, Malloy PJ et al (1996) The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 11:1850–1855PubMedCrossRef Gross C, Ecceleshall TR, Malloy PJ et al (1996) The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 11:1850–1855PubMedCrossRef
7.
go back to reference Saijo T, Naito E, Ito M et al (1991) Therapeutic effect of sodium dichloroacetate on visual and auditory hallucinations in a patient with MELAS. Neuropediatrics 22:166–167PubMedCrossRef Saijo T, Naito E, Ito M et al (1991) Therapeutic effect of sodium dichloroacetate on visual and auditory hallucinations in a patient with MELAS. Neuropediatrics 22:166–167PubMedCrossRef
8.
go back to reference Schurzenbecker L, Scardaville B, Kratzeisen C et al (1994) Isolation and analysis of cDNA encoding a naturally occurring truncated form of the human vitamin D receptor. In: Bouilon R, Norman A, Thomasset M (eds) Vitamin D: a pluripotent steroid hormone: structural studies, molecular endocrinology and clinical applications. Walter de Gruyter, Berlin, pp 253–257 Schurzenbecker L, Scardaville B, Kratzeisen C et al (1994) Isolation and analysis of cDNA encoding a naturally occurring truncated form of the human vitamin D receptor. In: Bouilon R, Norman A, Thomasset M (eds) Vitamin D: a pluripotent steroid hormone: structural studies, molecular endocrinology and clinical applications. Walter de Gruyter, Berlin, pp 253–257
9.
go back to reference Scott CM, Narasimha S, WenRong X, Rahul R (2001) Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1α, 25-dihydroxyvitamin D3 receptor? Steroid 66:189–2001. doi:10.1016/S0039-128X(00)00134-3 CrossRef Scott CM, Narasimha S, WenRong X, Rahul R (2001) Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1α, 25-dihydroxyvitamin D3 receptor? Steroid 66:189–2001. doi:10.​1016/​S0039-128X(00)00134-3 CrossRef
12.
13.
go back to reference Schaid DJ, Rowland CM, Tines DE et al (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425–434. doi:10.1086/338688 PubMedCrossRef Schaid DJ, Rowland CM, Tines DE et al (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425–434. doi:10.​1086/​338688 PubMedCrossRef
18.
go back to reference Gennari L, Becherini L, Mansani R et al (1999) FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women. J Bone Miner Res 14:1379–1386. doi:10.1359/jbmr.1999.14.8.1379 PubMedCrossRef Gennari L, Becherini L, Mansani R et al (1999) FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women. J Bone Miner Res 14:1379–1386. doi:10.​1359/​jbmr.​1999.​14.​8.​1379 PubMedCrossRef
20.
go back to reference Zhang Y, Rosenberg L, Colton T et al (1996) Adult height and risk of breast cancer among white women in a case–control study. Am J Epidemiol 143:1123–1128PubMed Zhang Y, Rosenberg L, Colton T et al (1996) Adult height and risk of breast cancer among white women in a case–control study. Am J Epidemiol 143:1123–1128PubMed
Metadata
Title
Vitamin D receptor variants and breast cancer risk in the Polish population
Authors
P. Gapska
R. J. Scott
P. Serrano-Fernandez
T. Huzarski
T. Byrski
J. Kładny
J. Gronwald
B. Górski
C. Cybulski
J. Lubinski
T. Dębniak
Publication date
01-06-2009
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2009
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0107-1

Other articles of this Issue 3/2009

Breast Cancer Research and Treatment 3/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine